TABLE OF CONTENTS
1 INTRODUCTION 27
1.1 OBJECTIVES OF THE STUDY 27
1.2 MARKET DEFINITION 27
1.3 OVERVIEW 27
1.4 LIMITATIONS 29
1.5 MARKETS COVERED 29
2 MARKET SEGMENTATION 31
2.1 MARKETS COVERED 31
2.2 GEOGRAPHICAL SCOPE 32
2.3 YEARS CONSIDERED FOR THE STUDY 33
2.4 CURRENCY AND PRICING 33
2.5 DBMR TRIPOD DATA VALIDATION MODEL 34
2.6 MULTIVARIATE MODELLING 37
2.7 CARDIAC MONITORING DEVICES LIFELINE CURVE 37
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 38
2.9 DBMR MARKET POSITION GRID 39
2.10 MARKET APPLICATION COVERAGE GRID 40
2.11 VENDOR SHARE ANALYSIS 41
2.12 SECONDARY SOURCES 42
2.13 ASSUMPTIONS 42
3 EXECUTIVE SUMMARY 43
4 PREMIUM INSIGHTS 46
4.1 PORTERS FIVE FORCES 47
4.2 VALUE CHAIN ANALYSIS: 48
4.3 COMPETITIVE ANALYSIS 49
4.4 BRAND ANALYSIS 51
4.5 ECOSYSTEM MAPS 52
4.6 TECHNOLOGICAL TRENDS 53
4.7 TOP WINNING STRATEGIES 54
5 MARKET OVERVIEW 55
5.1 DRIVERS 57
5.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES 57
5.1.2 GROWTH IN TECHNOLOGICAL ADVANCEMENTS 57
5.1.3 INCREASING DEMAND FOR REMOTE PATIENT MONITORING 59
5.1.4 INCREASING GOVERNMENT INITIATIVES 59
5.2 RESTRAINTS 60
5.2.1 STRICT REGULATORY FRAMEWORK 60
5.2.2 LACK OF STANDARDIZATION 61
5.3 OPPORTUNITIES 61
5.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS 61
5.3.2 PROVIDES QUICK AND REAL TIME RESULTS 62
5.4 CHALLENGES 63
5.4.1 LACK OF SKILLED PROFESSIONALS 63
5.4.2 RISK TO PATIENT'S DATA SECURITY 63
6 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE 65
6.1 OVERVIEW 66
6.2 CARDIAC MONITORING DEVICES 69
6.3 BLOOD PRESSURE MONITORING DEVICES 70
6.4 MULTI-PARAMETER MONITORING DEVICES 71
6.5 BLOOD GLUCOSE MONITORING DEVICES 72
6.6 RESPIRATORY MONITORING DEVICES 73
6.7 NEUROLOGICAL MONITORING DEVICES 74
6.8 OTHERS 75
7 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION 76
7.1 OVERVIEW 77
7.2 CARDIOVASCULAR DISEASE 80
7.2.1 CORONARY HEART DISEASE 81
7.2.2 STROKE 81
7.2.3 PERIPHERAL ARTERIAL DISEASE 81
7.2.4 AORTIC DISEASE 81
7.2.5 OTHERS 81
7.3 DIABETES 81
7.4 ONCOLOGY 82
7.5 OTHERS 83
8 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER 84
8.1 OVERVIEW 85
8.2 HOME HEALTHCARE PATIENTS 88
8.2.1 BLOOD GLUCOSE MONITORING DEVICES 89
8.2.2 CARDIAC MONITORING DEVICES 89
8.2.3 BLOOD PRESSURE MONITORING DEVICES 89
8.2.4 MULTI-PARAMETER MONITORING DEVICES 89
8.2.5 RESPIRATORY MONITORING DEVICES 89
8.2.6 NEUROLOGICAL MONITORING DEVICES 89
8.2.7 OTHERS 90
8.3 AMBULATORY PATIENTS 90
8.3.1 MULTI-PARAMETER MONITORING DEVICES 91
8.3.2 RESPIRATORY MONITORING DEVICES 91
8.3.3 CARDIAC MONITORING DEVICES 91
8.3.4 BLOOD PRESSURE MONITORING DEVICES 91
8.3.5 BLOOD GLUCOSE MONITORING DEVICES 91
8.3.6 NEUROLOGICAL MONITORING DEVICES 91
8.3.7 OTHERS 92
8.4 HOSPITAL-BASED PATIENTS 92
8.4.1 MULTI-PARAMETER MONITORING DEVICES 93
8.4.2 CARDIAC MONITORING DEVICES 93
8.4.3 RESPIRATORY MONITORING DEVICES 93
8.4.4 BLOOD PRESSURE MONITORING DEVICES 93
8.4.5 BLOOD GLUCOSE MONITORING DEVICES 93
8.4.6 NEUROLOGICAL MONITORING DEVICES 93
8.4.7 OTHERS 94
9 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION 95
9.1 MIDDLE EAST AND AFRICA 96
9.1.1 SOUTH AFRICA 104
9.1.2 EGYPT 108
9.1.3 ISRAEL 112
9.1.4 UAE 116
9.1.5 SAUDI ARABIA 120
9.1.6 REST OF MIDDLE EAST AND AFRICA 124
10 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, COMPANY LANDSCAPE 125
10.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 125
11 SWOT ANALYSIS 126
12 COMPANY PROFILE 127
12.1 MEDTRONIC 127
12.1.1 COMPANY SNAPSHOT 127
12.1.2 REVENUE ANALYSIS 128
12.1.3 COMPANY SHARE ANALYSIS 128
12.1.4 PRODUCT PORTFOLIO 129
12.1.5 RECENT DEVELOPMENT 129
12.2 DEXCOM, INC. 130
12.2.1 COMPANY SNAPSHOT 130
12.2.2 REVENUE ANALYSIS 130
12.2.3 COMPANY SHARE ANALYSIS 131
12.2.4 PRODUCT PORTFOLIO 131
12.2.5 RECENT DEVELOPMENT 131
12.3 ABBOTT 132
12.3.1 COMPANY SNAPSHOT 132
12.3.2 REVENUE ANALYSIS 132
12.3.3 COMPANY SHARE ANALYSIS 133
12.3.4 PRODUCT PORTFOLIO 133
12.3.5 RECENT DEVELOPMENT 133
12.4 RESMED 134
12.4.1 COMPANY SNAPSHOT 134
12.4.2 REVENUE ANALYSIS 134
12.4.3 COMPANY SHARE ANALYSIS 135
12.4.4 PRODUCT PORTFOLIO 135
12.4.5 RECENT DEVELOPMENT 135
12.5 BIOTRONIK SE & CO. KG 136
12.5.1 COMPANY SNAPSHOT 136
12.5.2 COMPANY SHARE ANALYSIS 136
12.5.3 PRODUCT PORTFOLIO 137
12.5.4 RECENT DEVELOPMENT 137
12.6 100 PLUS. 138
12.6.1 COMPANY SNAPSHOT 138
12.6.2 PRODUCT PORTFOLIO 138
12.6.3 RECENT DEVELOPMENTS 138
12.7 A&D COMPANY, LIMITED 139
12.7.1 COMPANY SNAPSHOT 139
12.7.2 REVENUE ANALYSIS 139
12.7.3 COMPANY SHARE ANALYSIS 140
12.7.4 PRODUCT PORTFOLIO 140
12.7.5 RECENT DEVELOPMENT 140
12.8 AEROTEL MEDICAL SYSTEMS 141
12.8.1 COMPANY SNAPSHOT 141
12.8.2 PRODUCT PORTFOLIO 141
12.8.3 RECENT DEVELOPMENT 141
12.9 ALIVECOR, INC. 142
12.9.1 COMPANY SNAPSHOT 142
12.9.2 COMPANY SHARE ANALYSIS 142
12.9.3 PRODUCT PORTFOLIO 142
12.9.4 RECENT DEVELOPMENTS 143
12.10 BIOBEAT 144
12.10.1 COMPANY SNAPSHOT 144
12.10.2 PRODUCT PORTFOLIO 144
12.10.3 RECENT DEVELOPMENT 144
12.11 BOSTON SCIENTIFIC CORPORATION 145
12.11.1 COMPANY SNAPSHOT 145
12.11.2 REVENUE ANALYSIS 146
12.11.3 COMPANY SHARE ANALYSIS 146
12.11.4 PRODUCT PORTFOLIO 146
12.11.5 RECENT DEVELOPMENT 147
12.12 CARDIOMO 148
12.12.1 COMPANY SNAPSHOT 148
12.12.2 PRODUCT PORTFOLIO 148
12.12.3 RECENT DEVELOPMENTS 148
12.13 CHRONISENSE MEDICAL, LTD. 149
12.13.1 COMPANY SNAPSHOT 149
12.13.2 PRODUCT PORTFOLIO 149
12.13.3 RECENT DEVELOPMENT 149
12.14 COACHCARE 150
12.14.1 COMPANY SNAPSHOT 150
12.14.2 PRODUCT PORTFOLIO 150
12.14.3 RECENT DEVELOPMENT 150
12.15 GENERAL ELECTRIC 151
12.15.1 COMPANY SNAPSHOT 151
12.15.2 REVENUE ANALYSIS 151
12.15.3 COMPANY SHARE ANALYSIS 152
12.15.4 PRODUCT PORTFOLIO 152
12.15.5 RECENT DEVELOPMENT 152
12.16 KONINKLIJKE PHILIPS N.V. 153
12.16.1 COMPANY SNAPSHOT 153
12.16.2 REVENUE ANALYSIS 153
12.16.3 COMPANY SHARE ANALYSIS 154
12.16.4 PRODUCT PORTFOLIO 154
12.16.5 RECENT DEVELOPMENT 154
12.17 MASIMO 155
12.17.1 COMPANY SNAPSHOT 155
12.17.2 REVENUE ANALYSIS 155
12.17.3 COMPANY SHARE ANALYSIS 156
12.17.4 PRODUCT PORTFOLIO 156
12.17.5 RECENT DEVELOPMENT 156
12.18 NETEERA 157
12.18.1 COMPANY SNAPSHOT 157
12.18.2 PRODUCT PORTFOLIO 157
12.18.3 RECENT DEVELOPMENT 157
12.19 NIHON KOHDEN CORPORATION 158
12.19.1 COMPANY SNAPSHOT 158
12.19.2 REVENUE ANALYSIS 158
12.19.3 COMPANY SHARE ANALYSIS 159
12.19.4 PRODUCT PORTFOLIO 159
12.19.5 RECENT DEVELOPMENT 159
12.20 OMRON CORPORATION 160
12.20.1 COMPANY SNAPSHOT 160
12.20.2 REVENUE ANALYSIS 160
12.20.3 COMPANY SHARE ANALYSIS 161
12.20.4 PRODUCT PORTFOLIO 161
12.20.5 RECENT DEVELOPMENT 161
12.21 SENSEONICS, INC. 162
12.21.1 COMPANY SNAPSHOT 162
12.21.2 REVENUE ANALYSIS 162
12.21.3 COMPANY SHARE ANALYSIS 163
12.21.4 PRODUCT PORTFOLIO 163
12.21.5 RECENT DEVELOPMENT 163
12.22 VITALCONNECT 164
12.22.1 COMPANY SNAPSHOT 164
12.22.2 PRODUCT PORTFOLIO 164
12.22.3 RECENT DEVELOPMENT 164
12.23 VITLS 165
12.23.1 COMPANY SNAPSHOT 165
12.23.2 PRODUCT PORTFOLIO 165
12.23.3 RECENT DEVELOPMENT 165
12.24 VIVIFY HEALTH INC. 166
12.24.1 COMPANY SNAPSHOT 166
12.24.2 PRODUCT PORTFOLIO 166
12.24.3 RECENT DEVELOPMENTS 166
12.25 WITHINGS 167
12.25.1 COMPANY SNAPSHOT 167
12.25.2 COMPANY SHARE ANALYSIS 167
12.25.3 PRODUCT PORTFOLIO 167
12.25.4 RECENT DEVELOPMENT 168
13 QUESTIONNAIRE 169
14 RELATED REPORTS 172

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.